Is Palmoplantar Psoriasis Considered a Disability?

Palmoplantar Psoriasis (PPP) is a chronic autoimmune condition that specifically affects the skin of the palms of the hands and the soles of the feet. This localized but highly symptomatic variant of psoriasis can significantly interfere with a person’s ability to perform daily functions and maintain employment. The core question is whether the severity of this condition meets the rigorous legal definition necessary to qualify for disability status. This determination hinges not on the diagnosis itself, but on the documented, measurable limitations the disease imposes on an individual’s work capacity.

Understanding Palmoplantar Psoriasis

Palmoplantar psoriasis is characterized by patches of red, thickened skin, often covered in scales or sterile pustules (palmoplantar pustulosis). The lesions are intensely painful and frequently accompanied by deep cracks, or fissures, that form in the thick, dry plaques. Because the palms and soles are subjected to constant pressure and friction, these lesions are prone to splitting, making movement uncomfortable.

The unique location of the condition makes it disproportionately impactful compared to other forms of psoriasis. Even a small area of involvement can render the hands or feet functionally impaired. This manifestation results from an accelerated life cycle of skin cells, which build up rapidly instead of shedding normally.

Functional Limitations and Daily Impact

The physical symptoms of PPP translate directly into significant functional impairment. For the hands, the condition severely compromises dexterity and grip strength, making fine motor skills difficult or impossible. Activities become sources of intense pain and limitation, including:

  • Grasping a pen
  • Typing on a keyboard
  • Handling tools
  • Turning doorknobs

The impact on the feet is equally severe, directly limiting mobility and weight-bearing capacity. Walking, standing for extended periods, and even wearing standard footwear can cause severe pain due to the fissuring and thickening of the plantar skin. This can translate into an inability to perform jobs that require standing, walking, or prolonged sitting with feet on the floor.

The localized disease creates a scenario where the physical disability is far greater than the percentage of skin affected might suggest. The chronic nature of the condition, often characterized by painful flares despite treatment, means these limitations are long-term and unpredictable. The inability to use the hands or feet effectively prevents a person from performing the sustained physical activities required in most occupations.

Legal Criteria for Disability Status

Palmoplantar Psoriasis is evaluated based on its severity and documented effect on the ability to work, not as an automatic disability. In the United States, the Social Security Administration (SSA) assesses skin conditions under the Listing of Impairments. To meet the criteria, the condition must be “extensive” and persist for at least three months despite continuing prescribed medical treatment.

“Extensive” lesions are defined as those that involve multiple body sites or significantly interfere with work-related function. For PPP, this means the lesions must prevent the use of the hands for fine and gross movements, or the feet for walking and standing. Meeting these criteria means the condition is considered medically equivalent to a listed impairment.

If the severity does not meet a specific listing, the claim is evaluated based on the Residual Functional Capacity (RFC). The RFC assessment determines the maximum amount of work the individual can still perform despite their limitations. This process considers how pain, discomfort, and inability to stand, walk, or manipulate objects limit the ability to perform past work or adjust to other work available in the national economy.

Required Documentation for a Claim

A successful claim relies on comprehensive medical evidence that objectively documents the severity and functional consequences of PPP. Longitudinal medical records from a dermatologist or rheumatologist are necessary to show the chronic nature of the disease and the history of treatment attempts. Documentation of non-responsive treatments (e.g., topical medications, phototherapy, or systemic agents) is important to establish that the condition persists despite professional medical intervention.

Physician notes must include specific statements detailing the functional limitations imposed by the lesions, going beyond a mere diagnosis. This includes measurable restrictions, such as the maximum time an individual can stand or walk, or the inability to perform fine manipulation. Objective evidence, such as clinical photographs and detailed records of flare-ups and pain levels, strengthens the claim by illustrating the physical extent of the impairment.